Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Social Class, Gender And Ethnic Group Determine Adolescents' Sexual-Affective Education
The social class, the gender and the ethnic group are three essential dimensions, not only in the social differentiation, but also in the affective sexual education of the adolescents, where it is necessary to take part in order to promote sexual and gender equity and prevent gender violence. This is one of the main conclusions of the investigation Affective sexual policy: a sociological approach to affective sexual education", carried out by the researcher of the department of Sociology of the University of Granada Mar Venegas Medina and supervised by professor Francisco Fernández Palomares. Don't forget to buy zoloft online no prescription.

Novel Strategy For Treating Obesity Suggested By Creation of Energy-Burning Brown Fat In Mice
Researchers at Dana-Farber Cancer Institute have shown that they can engineer mouse and human cells to produce brown fat, a natural energy-burning type of fat that counteracts obesity. If such a strategy can be developed for use in people, the scientists say, it could open a novel approach to treating obesity and diabetes.

generic viagra online


News of the day
EmblemHealth Provides New Medical Manual To Help Clinicians Address Religio-Cultural Issues That Influence Health Care Decisions
To meet the needs of its diverse clinician and patient constituency, EmblemHealth announced on Friday publication of what is believed to be the first comprehensive guide to help physicians and medical professionals address the needs of patients whose health care decisions are influenced by their religious and cultural beliefs. The Medical Manual for Religio-Cultural Competency is sponsored by EmblemHealth and created by the Tanenbaum Center For Interreligious Understanding, a global leader in training health care providers to offer religiously and culturally competent care for patients of all ages and backgrounds.
Public Health

2009 American Transplant Congress (ATC), Boston

NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists are presenting exciting new research at the 2009 American Transplant Congress in Boston from May 30 to June 3. Dr. Sandip Kapur, chief of transplant surgery and director of kidney and pancreas transplant programs at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Dr. Manikkam Suthanthiran, chairman of the Department of Transplantation Medicine and chief of the Division of Nephrology and Hypertension at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, are both available for comment on the following studies and on other news from the conference. Alterations in MicroRNA Predict Rejection and May Be Novel Treatment Target [1016] Poster Session: Basic Mechanisms of Acute Rejection I Sunday, May 31, 5:30 p.m.; Exhibit Hall C Authors: Dany Anglicheau, Vijay Sharma, Ruchuang Ding, Aurç©lie Hummel, Catherine Snopkowski, Darshana Dadhania, Surya Seshan, Manikkam Suthanthiran The authors have identified differences in the expression of microRNAs between patients who experienced kidney rejection and those with successful long-term transplants. MicroRNAs are a newly discovered group of genes that control a wide variety of biological process. The researchers found that rejection can be predicted with a greater than 95 percent accuracy by screening for the changes in expression of very few microRNAs. In addition to serving as a novel diagnostic test, microRNA profiles may predict the development of transplant rejection and response to anti-rejection treatment. Moreover, the researchers hope to develop safe and personalized treatment using microRNA profiles to guide therapy. From Concept to Reality: Increasing Transplantation Through Donor Chains [319] Concurrent Session 45: Kidney Living Donor Paired Exchange/Donor Chains Monday, June 1, 4:12 p.m.; Room 302/304 Authors: David Leeser, Meredith Aull, Judith Hambleton, David Serur, Garet Hil, Darshana Dadhania, Marian Charlton, Sandip Kapur Approximately one-third of kidney transplant candidates with the potential to receive a transplant from a living donor will be incompatible due to blood type or immune system reactivity against the donor. Registries such as the National Kidney Registry have been developed to match incompatible donor/recipient pairs with more acceptable donors and recipients. In addition, altruistic donors, who do not have an intended recipient, are entered into the registry to increase the pool of potential donors. This system has allowed NewYork-Presbyterian/Weill Cornell to transplant 70 percent of incompatible pairs. Transplanting Islet Cells Without Use of Toxic Drugs [154] Concurrent Session 22: Novel Methods of Immune Regulation in Islet Transplantation Sunday, May 31, 4:12 p.m.; Room 312 Authors: Elaine Cheng, Raymond Weir, Mila Lagman, Vijay Sharma, Manikkam Suthanthiran, Hua Yang Researchers will present their results demonstrating the ability of a specialized type of cells, called T regulatory cells, to protect pancreatic islet cell transplants in mice and eliminate the need for standard immunosuppressive drugs. Since the drugs currently used to treat islet cell transplantation are toxic to the islet cells themselves, a T regulatory cell-based treatment regimen in the clinic may have significant advantages over the current treatments. Transplanting Single Kidneys From Donors Under 5 Years of Age Into Standard Adult Recipients: Can We Achieve Optimal Outcomes? [92] Concurrent Session 13: Pediatric and DCD Donors Sunday, May 31, 2:39 p.m.; Room 208 Authors: Vinod Balachandran, Meredith Aull, Maria Goris, Jose Figueiro, David Leeser, Sandip Kapur Researchers will present their results showing that average-sized adults receiving a single kidney from pediatric donors less than five years of age have similar outcomes to adults receiving a kidney from an adult donor. Historically, adults receiving transplants from young donors were given both kidneys because it was thought that a single pediatric kidney could not provide adequate renal function for an adult. This practice has the potential to increase the organ donor pool. Non-invasive Urine Test for Diagnosis of Most Common Kidney Transplant Complications [122] Concurrent Session 17: Immune Monitoring: Chronic Allograft Damage and Chronic Humoral Rejection Sunday, May 31, 4:48 p.m.; Room 309 Authors: Thangamani Muthukumar, Ruchuang Ding, Catherine Snopkowski, Aurç©lie Hummel, Vijay Sharma, Darshana Dadhania, Surya Seshan, Manikkam Suthanthiran, Dany Anglicheau The authors will present their findings about the development and validation of a new gene-based urine test for the diagnosis of renal interstitial fibrous and tubular atrophy (scarring of the kidney transplant) - the most common cause of kidney transplant failure. Before now, an invasive biopsy test was the only way to diagnose the condition. Older Living Donors Provides Excellent Outcomes After Kidney Transplantation [532] Concurrent Session 74: Kidney Living Donor Outcomes I Tuesday, June 2, 5:00 p.m.; Ballroom C Authors: Vinod Balachandran, David Leeser, Meredith Aull, Marian Charlton, Jose Figueiro, David Serur, Joseph Del Pizzo, Sandip Kapur Some transplant centers avoid accepting older living donors due to concerns over inferior kidney function in the recipient. The authors have shown that equivalent outcomes can be achieved with transplantation of kidneys from donors older than 50 years when compared with donors younger than 50. It was noted that kidney function was lower, though acceptable, in recipients of kidneys from donors over 70 years of age. Predicting Kidney Function in Transplant Patients With BK Virus Infection [1558] Poster Session: Strategies in Immune Monitoring Monday, June 1, 5:30 p.m.; Exhibit Hall C Authors: Darshana Dadhania, Catherine Snopkowski, Thangamani Muthukumar, Jun Lee, Vijay Sharma, Ruchuang Ding, Surya Seshan, Manikkam Suthanthiran BK virus infection has emerged as a major complication in transplant recipients, and almost 50 percent of transplant patients with BK virus infection go on to lose their transplants. Until now, it has been difficult to predict which patients will have a bad outcome and those who will not. The authors have developed a new molecular test to identify patients at risk for disease progression. Charlson Comorbidity Index Predicts Patient Survival Independent of Age Following Deceased Donor Renal Transplantation [107] Concurrent Session 15: Donor/Recipient Factors and SCDs Sunday, May 31, 4:48 p.m.; Room 210 Authors: David Leeser, Meredith Aull, Ryan Cauley, Jose Figueiro, Sandip Kapur Charlson Comorbidty Index (CCI) scores may be a novel tool to assess whether kidney transplant candidates will do well after transplant. The authors found that patients with a higher CCI score have a higher risk of death and graft loss if they receive a donor organ from someone older and/or with comorbidties, but do well if they receive a standard donor organ. Andrew Klein New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009